Monday, May 20, 2013 Last update: 1:03 PM
Company Tech News as it Breaks
Insmed
News articles for Insmed:
Monday, March 11, 2013
- Insmed to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call on Monday, March 18, 2013MONMOUTH JUNCTION, NJ -- (Marketwire) -- 03/11/13 -- Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious orphan lung diseases that are often life-threatening, today announced that the Company will release financial results for the three and twelve months ended ... read more
Tuesday, February 26, 2013
- Insmed to Present at Two Upcoming Investor ConferencesMONMOUTH JUNCTION, NJ -- (Marketwire) -- 02/26/13 -- Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious orphan lung diseases that are often life-threatening, today announced that members of Insmed's management team will be presenting the Company's corporate overview at ... read more
Wednesday, February 6, 2013
- Insmed to Present at Two Upcoming Healthcare Investor ConferencesMONMOUTH JUNCTION, NJ -- (Marketwire) -- 02/06/13 -- Insmed Incorporated (NASDAQ: INSM), a biopharmaceutical company focused on developing and commercializing inhaled therapies for patients battling serious orphan lung diseases that are often life-threatening, today announced that Will Lewis, President and Chief Executive Officer of Insmed, will be presenting a ... read more